PD GENEration Clinical Phase: Genetic Diagnostic Yield and Clinical Characteristics
Objective: To assess the frequency of reportable variants in major genes associated with Parkinson’s disease (PD) and identify clinical predictors of positive genetic test results.…Early intervention with deep brain stimulation for children with ε-sarcoglycan myoclonus dystonia
Objective: To evaluate the efficacy and safety of Globus Pallidus Internus DBS (GPi-DBS) in early stages of disease course. Background: SGCE-related myoclonus-dystonia (SGCE-MD) is considered…GNAO1 related disorders: a clinical, genetic, and therapeutic update
Objective: To review the clinical phenotype and molecular findings of 125 cases with GNAO1-related disorders, delineating the typical phenotype and the phenotypic expansions and tracing…The Unmet needs for advanced Parkinson Disease in -Patients’ during the Covid-19 pandemic in Israel
Objective: To evaluate the socio-demographic profile and clinical needs of advanced Parkinson's disease patients who were admitted to the neurological department at TASMC during the…Feasibility of telephonic voice samples to remotely monitor people with Parkinson’s disease residing in medically underserved rural regions
Objective: To explore the feasibility of collecting voice samples using digital voicemail in People with Parkinson’s disease (PwPD). Background: For many PwPD, the increased adoption…Characteristics and validity of technologies analyzing voice features to assess symptoms – a review
Objective: Our goal was to review the current literature aiming to (i) list, (ii) compare and (iii) classify voice-based technologies that objectively measure the presence…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.